Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
505–540
Headlines
2039
Sources here
23
Companies here
24
Current section United States Medical Care Facilities news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Chemed Corp (CHE) Stock News Today

This page provides current stock news, earnings, analyst ratings, and key developments for Chemed Corp (CHE). The article states that more news will be available soon. It also includes basic financial data such as the stock price, market cap, and P/E ratio.

CHE main company
Sharemaestro market context Trend signal active 52 weeks +24.7% CHE stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Option Care Health (OPCH) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, July 29, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Bob OkunskiPresident and Chief Executive Officer - John Charles RademacherExecutive Vice President and Chief Financial Officer - Meenal Anil Sethna Need a …

OPCH main company
Sharemaestro market context Price below Trend Line 52 weeks -16.7% OPCH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex outlines 3 hospital openings in H2 2026 while maintaining 3 to 5 openings per year

Earnings Call Insights: Nutex Health (NUTX) Q2 2026 MANAGEMENT VIEW * "It was an active quarter, marked by strong financial results, important reimbursement developments and continued progress on our growth pipeline" (Chairman of the Board & CEO Thomas Vo). * "On the vendor front, …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Understanding Momentum Shifts in (CHE)

This article analyzes Chemed Corp (NYSE: CHE) using AI models to identify potential momentum shifts. Key findings suggest that strong near and mid-term sentiment could extend to the long term, with no resistance levels above the current price, indicating upside potential. The analysis provides …

CHE main company
Sharemaestro market context Trend signal active 52 weeks +24.7% CHE stored weekly price path from 15 Aug 2025 to 7 Aug 2026

New CDC Director Schwartz Exits Aveanna Board

Dr. Erica Schwartz, the new director of the Centers for Disease Control and Prevention (CDC), has resigned from her position on the board of Aveanna Healthcare Holdings (Nasdaq: AVAH). This resignation is a direct result of her nomination and confirmation as CDC director, as …

AVAH main company
Sharemaestro market context Trend signal active 52 weeks +64.9% AVAH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What Pennant Group (PNTG)'s Q2 Beat, Guidance Hike and New Acquisition Means For Shareholders

The Pennant Group reported strong Q2 2026 results, surpassing revenue and net income expectations, and subsequently raised its full-year 2026 revenue guidance. This positive financial performance is further bolstered by the strategic acquisition of the 63-unit River Centre Assisted Living community, expanding its senior …

PNTG main company
Sharemaestro market context Trend signal active 52 weeks +56.2% · Next-week setup positive 57.7% PNTG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fresenius Medical Care AG 2026 Q2 - Results - Earnings Call Presentation (NYSE:FMS) 2026-08-07

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026, at 9:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer and Chair of the Management Board - Helen Giza Chief Financial Officer - Martin Fischer Investor Relations - Dominik Heger Full Conference Call Transcript Operator: …

FMS main company
Sharemaestro market context Trend signal active 52 weeks +0.7% FMS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

AMN Healthcare Services Crushes Q2 2026 Profit Estimates by 305.3%

AMN Healthcare Services (NYSE:AMN) reported a significant beat in its Q2 2026 earnings, with adjusted diluted EPS of $0.77 against an estimated $0.19, reflecting a 305.3% beat. Revenue increased 2.0% year-over-year to $673.2M, driven by strong performance in the Nurse and Allied Solutions division. …

AMN main company
Sharemaestro market context Trend signal active 52 weeks +90.3% AMN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

AMN Healthcare (NYSE: AMN) posts $2.05B H1 revenue and strong cash flow

AMN Healthcare Services reported a significant increase in first-half 2026 revenue to $2.05 billion, a 52% rise year-over-year, primarily driven by labor disruption staffing in its nurse and allied solutions segment. The company returned to profitability with a net income of $83.3 million for …

AMN main company
Sharemaestro market context Trend signal active 52 weeks +90.3% AMN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

AIRSCULPT TECHNOLOGIES Q2 2026 Earnings Preview: Recent $AIRS Insider Trading, Hedge Fund Activity, and More

AIRSCULPT TECHNOLOGIES ($AIRS) is set to release its Q2 2026 earnings on August 10th, with analysts expecting $45 million in revenue and $0.01 EPS. Insider trading activity shows 13 purchases totaling $1.98 million in the past six months, with no sales. Hedge fund activity …

AIRS main company
Sharemaestro market context Trend signal active 52 weeks -47.2% AIRS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AirSculpt Technologies Inc expected to post earnings of 1 cent a share - Earnings Preview

AirSculpt Technologies Inc (NASDAQ: AIRS) is projected to report earnings of 1 cent per share. This information is based on an earnings preview from Refinitiv, indicating upcoming financial results for the company. The full article is available for unlimited access through TradingView's news services.

AIRS main company
Sharemaestro market context Trend signal active 52 weeks -47.2% AIRS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

HCA Buys Texas Urgent-Care Venture

HCA Healthcare Inc. has acquired Texas MedClinic, a chain of 40 urgent-care centers, significantly expanding its national network by over 10%. The acquired clinics in Houston, San Antonio, and Austin have been rebranded as CareNow. This acquisition aligns with HCA's long-term strategy to bolster …

HCA main company
Sharemaestro market context Price below Trend Line 52 weeks +5.2% · Next-week setup positive 56.1% HCA stored weekly price path from 15 Aug 2025 to 7 Aug 2026

WW (WW) Stock Rallies On Margin Strength As Revenue Shrinks

WW International (WW) stock rallied 9.5% after its Q2 2026 earnings, despite a 14.2% revenue decline, due to strong margin resilience with gross margin holding at 70.3%. The company's strategy to shift towards clinical and higher-value behavioral tiers is showing progress, with clinical revenue …

WW main company
Sharemaestro market context Price above Trend Line 52 weeks -42.9% · Next-week setup negative 40.5% WW stored weekly price path from 15 Aug 2025 to 7 Aug 2026

WW (WW) Stock Jumps As Profit Returns But Revenue Shrinks

WW International (WW) stock jumped 9.5% after reporting a profitable quarter with US$14.1m in net income and strong gross margins, driven by investor perception that its clinical weight loss drug and digital programs can support high margins and debt reduction. While clinical revenue and …

WW main company
Sharemaestro market context Price above Trend Line 52 weeks -42.9% · Next-week setup negative 40.5% WW stored weekly price path from 15 Aug 2025 to 7 Aug 2026

El Pasoan wins top award from Acadia Healthcare

Donna Juarez, an El Paso healthcare professional, has been awarded the prestigious Values in Action Peak Award by Acadia Healthcare. Juarez, who serves as the director of military veteran affairs for Rio Vista Behavioral Health, was selected from 500 nominees out of 29,000 employees. …

ACHC main company
Sharemaestro market context Trend signal active 52 weeks +37.4% ACHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

The Oncology Institute, Inc. (STLN) Income Statement

The article provides the income statement for The Oncology Institute, Inc. (STLN) showing financial data for annual and quarterly periods up to 2025-12-31, with a TTM (trailing twelve months) column. Key financial metrics such as total revenue, gross profit, operating income, and net income …

TOI main company
Sharemaestro market context Trend signal active 52 weeks +13.6% TOI stored weekly price path from 8 Aug 2025 to 31 Jul 2026

The Oncology Institute, Inc. $TOI Shares Bought by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership significantly increased its stake in The Oncology Institute, Inc. ($TOI) by 169.3% in the first quarter, now owning 419,423 shares valued at approximately $1.29 million. Other institutional investors like Goldman Sachs and Geode Capital Management also made notable changes to …

TOI main company
Sharemaestro market context Trend signal active 52 weeks +13.6% TOI stored weekly price path from 8 Aug 2025 to 31 Jul 2026

Oncology Institute Q2 Earnings Call Highlights

Oncology Institute reported strong Q2 revenue growth, positive adjusted EBITDA, and rebranded as Starling Oncology to reflect its evolution into a national value-based oncology provider. The company expanded its value-based contracts, adding new agreements in Nevada, Oregon, and California, which are expected to significantly …

TOI main company
Sharemaestro market context Trend signal active 52 weeks +13.6% TOI stored weekly price path from 8 Aug 2025 to 31 Jul 2026

Top Stock Reports for SpaceX, Arista Networks & Boeing

Friday, August 7, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Space Exploration Technologies Corp. (SPCX), Arista Networks, Inc. (ANET) and The Boeing Co. (BA). These …

EHC mentioned
Sharemaestro market context Trend signal active 52 weeks +4.6% EHC stored weekly price path from 15 Aug 2025 to 7 Aug 2026

SURGERY PARTNERS Q2 2026 Earnings Preview: Recent $SGRY Insider Trading, Hedge Fund Activity, and More

SURGERY PARTNERS ($SGRY) is set to release its Q2 2026 earnings on August 10th, with analysts expecting $846.97 million in revenue and $0.06 EPS. Recent insider trading shows 12 sales and no purchases in the last six months, totaling over $1.2 million in sales …

SGRY main company
Sharemaestro market context Trend signal active 52 weeks -36.4% · Next-week setup negative 39.0% SGRY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

HCA Healthcare Inc. stock underperforms Friday when compared to competitors despite daily gains

HCA Healthcare Inc. stock rose 1.09% to $413.36 on Friday, outperforming the S&P 500 Index and Dow Jones Industrial Average on a positive trading day. Despite these daily gains, the stock underperformed compared to its competitors. HCA Healthcare Inc. closed 25.72% below its 52-week …

HCA main company
Sharemaestro market context Price below Trend Line 52 weeks +5.2% · Next-week setup positive 56.1% HCA stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Concentra Group Holdings Parent Inc (CON) (Q2 2026) Earnings Call Highlights: Strong Revenue ...

This article first appeared on GuruFocus. Total Revenue: $606 million in Q2 2026, a 10% increase year-over-year from $550.8 million. Core Revenue Growth: Excluding Pivot acquisition, revenue was $589.1 million, an 8% increase over the prior year. Occupational Health Segment Revenue: $553.5 million, up …

CON main company
Sharemaestro market context Trend signal active 52 weeks +48.2% CON stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Analysts Are Updating Their Strata Critical Medical, Inc. (NASDAQ:SRTA) Estimates After Its Second-Quarter Results

Strata Critical Medical, Inc. (NASDAQ:SRTA) saw its shares rise 9.8% after its second-quarter results, despite a significant increase in statutory losses per share. Analysts have since updated their estimates, now predicting profitability for the company next year and a notable 12% improvement in 2026 …

SRTA main company
Sharemaestro market context Trend signal active 51 weeks +35.0% SRTA stored weekly price path from 29 Aug 2025 to 14 Aug 2026

Surgery Partners Inc (SGRY) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Surgery Partners Inc (SGRY), highlighting its current earnings forecast score, analyst ratings, and price targets. It details expected revenue and EPS for upcoming quarters and compares SGRY's ratings to its peers in the Healthcare Providers & Services …

SGRY main company
Sharemaestro market context Trend signal active 52 weeks -36.4% · Next-week setup negative 39.0% SGRY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

The Economy Lost Jobs, Wall Street Threw a Party: What Moved Markets This Week

The American economy shed 23,000 nonfarm payrolls in July. Wall Street answered with its best week since April. That is not a contradiction. It turns on the fact that has defined 2026 and that many investors still find uncomfortable: the Federal Reserve's next move …

DVA mentioned
Sharemaestro market context Trend signal active 52 weeks +35.7% DVA stored weekly price path from 15 Aug 2025 to 7 Aug 2026

The Pennant Group Leverages Technology in Hospice Growth

The Pennant Group (Nasdaq: PNTG) is heavily investing in technology, particularly AI, to enhance its hospice and home health operations, improve quality, and boost revenue. The company is piloting AI tools to streamline clinical documentation and back-office processes, aiming to increase clinical capacity and …

PNTG main company
Sharemaestro market context Trend signal active 52 weeks +56.2% · Next-week setup positive 57.7% PNTG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Barclays Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Barclays has maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (0H9X) with a price target of €44.50. This rating aligns with Goldman Sachs's Hold, while Jefferies reiterated a Sell rating on the company. Fresenius Medical Care currently has a market …

FMS main company
Sharemaestro market context Trend signal active 52 weeks +0.7% FMS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Here’s How Much You Would Have Made Owning Tenet Healthcare Stock In The Last 15 Years

Tenet Healthcare (NYSE: THC) has outperformed the market over the past 15 years with an average annual return of 18.6%. An initial investment of $100 in THC stock 15 years ago would now be worth $1,323.89, demonstrating the power of compounded returns. The company …

THC main company
Sharemaestro market context Trend signal started 52 weeks +52.4% · Next-week setup positive 55.5% THC stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Earnings call transcript: Nutex Health tops Q2 2026 profit estimates

Nutex Health (NUTX) reported a significant profit beat in Q2 2026, with adjusted earnings of $9.38 per share against an estimate of $4.88, despite revenue slightly missing forecasts at $210.75 million. The company's shares rose over 10% as investors reacted positively to stronger margins, …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LifeStance Health Group, Inc. Q2 2026: Revenue $435.4M, EPS $0.06— 10-Q Summary

LifeStance Health Group, Inc. reported strong Q2 2026 results, with revenue increasing to $435.4M from $345.3M year-over-year, and net income turning profitable at $23.6M compared to a loss of $3.8M in Q2 2025. Diluted EPS reached $0.06, up from $(0.01) in the prior-year quarter. …

LFST main company
Sharemaestro market context Trend signal active 52 weeks +123.8% LFST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LifeStance Health Group, Inc. Stock 12‑Month Price Target Raised to $12.6, Implies 22% Upside

LifeStance Health Group, Inc.'s average price target has been increased from $12 to $12.6 by 10 analysts, suggesting a 22% potential upside from its Aug. 5 closing price. The consensus rating for the stock remains a "Buy" across 11 analysts, with 9 recommending Buy …

LFST main company
Sharemaestro market context Trend signal active 52 weeks +123.8% LFST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context